WeVote

Bill

Bill

HD 2659

An Act to provide rapid whole genome sequencing

194th Legislature (2025-2026) Introduced by Danielle Gregoire

Massachusetts bill to establish rapid whole genome sequencing program, expanding genetic testing access but raising questions about funding, privacy protections, and clinical necessity standards.

0
WeVote Research Nonpartisan
Bill Summary · HD 2659

Legislative bill overview

HD 2659 would establish a program to provide rapid whole genome sequencing services in Massachusetts, likely for diagnostic or clinical purposes. The bill aims to make advanced genetic testing more accessible to residents, potentially through state health facilities or insurance coverage requirements.

Why is this important

Whole genome sequencing can identify genetic causes of diseases, inform treatment decisions, and enable early intervention for serious conditions. Expanding access to this technology could improve health outcomes, particularly for patients with rare or undiagnosed genetic disorders who currently face significant delays and costs.

Potential points of contention

  • Cost and funding: Whole genome sequencing is expensive; unclear how the state would fund this program and whether costs would be covered by insurance, taxpayers, or individuals
  • Clinical utility questions: Not all genetic findings are actionable; debate exists over when sequencing is medically necessary versus elective
  • Privacy and genetic data concerns: Storing genomic data raises issues about privacy protections, data security, potential discrimination by insurers or employers, and who controls the information
  • Implementation timeline: "Rapid" sequencing requires infrastructure investment; unclear if Massachusetts has capacity or what turnaround times are promised

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.